Goldman Sachs lowered CVS Health (NYSE:CVS) price target from $100 to $88By legume / May 26, 2023 / CVS Health, Goldman Sachs Goldman Sachs analyst Nathan Rice maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $100 to $88.